Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001851734-22-000438
Filing Date
2022-08-11
Accepted
2022-08-11 17:23:01
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arch20220630_10q.htm   iXBRL 10-Q 818601
2 EXHIBIT 31.1 ex_395650.htm EX-31.1 8896
3 EXHIBIT 31.2 ex_395651.htm EX-31.2 9036
4 EXHIBIT 32.1 ex_395652.htm EX-32.1 7405
  Complete submission text file 0001851734-22-000438.txt   4410181

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arch-20220630.xsd EX-101.SCH 47483
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arch-20220630_cal.xml EX-101.CAL 26693
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20220630_def.xml EX-101.DEF 341578
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20220630_lab.xml EX-101.LAB 263692
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20220630_pre.xml EX-101.PRE 360893
53 EXTRACTED XBRL INSTANCE DOCUMENT arch20220630_10q_htm.xml XML 595878
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 221157002
SIC: 3841 Surgical & Medical Instruments & Apparatus